/ IRWD
Why Is IRWD Stock Soaring Over 30% Premarket? 2026 Revenue Outlook Beats Estimates
Ironwood Pharmaceuticals shares surged more than 30% in premarket trading after the company issued 2026 revenue guidance above Wall Street estimates.
January 02, 2026